Primary coronary artery pseudoaneurysm in a patient with familial hypercholesterolemia

Toshiki Fujiyoshi1, Masaki Kano1, Hitoshi Ogino1

  • 1Department of Cardiovascular Surgery Tokyo Medical University Tokyo Japan.

Clinical Case Reports
|October 19, 2019
PubMed

Insights

Rare coronary artery pseudoaneurysms were successfully repaired in a young patient with heterozygous familial hypercholesterolemia (FH). Direct closure of intimal defects using aneurysmorrhaphy provided a successful treatment outcome.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Medicine
  • Genetics

Background:

  • Coronary artery pseudoaneurysms are rare vascular abnormalities.
  • Familial hypercholesterolemia (FH) is a genetic disorder that increases cardiovascular risk.
  • Young patients with FH may present with complex cardiovascular conditions.

Observation:

  • A young patient diagnosed with heterozygous familial hypercholesterolemia presented with a rare primary coronary artery pseudoaneurysm.
  • The pseudoaneurysm required a minimally invasive surgical intervention.

Findings:

  • Successful surgical repair of the coronary artery pseudoaneurysm was achieved.
  • The procedure involved direct closure of intimal defects.
  • Aneurysmorrhaphy was the specific surgical technique employed.

Implications:

  • This case demonstrates the feasibility of aneurysmorrhaphy for treating coronary artery pseudoaneurysms in young patients.
  • Effective management of such rare conditions in genetically predisposed individuals is crucial.
  • Direct intimal defect closure offers a viable therapeutic option, potentially reducing complications.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
328
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
837
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
274
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
321
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
287
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
251